In the presence of an IDO1 inhibitor, tryptophan levels can be increased and the accumulation can induce tumor regression by upregulating the production of IL-12 and IFN-γ cytokines and T cells and neutrophils in mouse metastastic liver and blade tumor models [12]. The gene discussed is IDO1; the disease is neoplasm.